Literature DB >> 4265890

Vascular effects of the dinitrate and moninitrate esters of isosorbide, isomannide and isoidide.

M G Bogaert, M T Rosseel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4265890     DOI： 10.1007/bf00500061

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN： 0028-1298            Impact factor:   3.000


× No keyword cloud information.
  7 in total

1.  Active relfex dilatation in the innervated perfused hind leg of the dog.

Authors:  L BECK
Journal:  Am J Physiol       Date:  1961-07

2.  Pharmacological properties of sorbide dinitrate.

Authors:  L GOLDBERG
Journal:  Acta Physiol Scand       Date:  1948-04-20

3.  Pharmacological properties of isoidide dinitrate.

Authors:  J E Halliday; S C Clark
Journal:  J Pharm Pharmacol       Date:  1965-05       Impact factor: 3.765

4.  Pharmacologic and biochemical evaluation of organic nitrates: attempted correlation of activities.

Authors:  S W Blum; J B Quinn; B B Howe; M A Hefner; M M Winbury
Journal:  J Pharmacol Exp Ther       Date:  1971-03       Impact factor: 4.030

5.  Isosorbide, isomannide and isoidide dinitrate: urinary excretion in the rat.

Authors:  M T Rosseel; M G Bogaert
Journal:  Biochem Pharmacol       Date:  1973-01-01       Impact factor: 5.858

6.  Relationship between glutathione-dependent dentration and the vasodilator effectiveness of organic nitrates.

Authors:  P Needleman; D J Blehm; K S Rotskoff
Journal:  J Pharmacol Exp Ther       Date:  1969-02       Impact factor: 4.030

7.  Systemic and coronary vascular effects of the 2- and the 5-mononitrate esters of isosorbide.

Authors:  R L Wendt
Journal:  J Pharmacol Exp Ther       Date:  1972-03       Impact factor: 4.030
  7 in total
  12 in total

1.  Understanding the hysteresis loop conundrum in pharmacokinetic/pharmacodynamic relationships.

Authors:  Christopher Louizos; Jaime A Yáñez; M Laird Forrest; Neal M Davies
Journal:  J Pharm Pharm Sci       Date:  2014       Impact factor: 2.327

2.  Portal and systemic haemodynamic response to acute and chronic administration of low and high dose isosorbide-5-mononitrate in patients with cirrhosis.

Authors:  A L Jones; I H Bangash; J Walker; K J Simpson; N D Finlayson; P C Hayes
Journal:  Gut       Date:  1995-01       Impact factor: 23.059

3.  Intra-individual comparison of the action of equal doses of isosorbide-5-endomononitrate, slow-release isosorbide dinitrate and placebo in patients with coronary heart disease.

Authors:  G Müller; W Häcker; B Schneider
Journal:  Klin Wochenschr       Date:  1983-04-15

4.  Concentrations of the vasodilator isosorbide dinitrate and its metabolites in the blood of human subjects.

Authors:  L F Chasseaud; W H Down; R K Grundy
Journal:  Eur J Clin Pharmacol       Date:  1975-04-04       Impact factor: 2.953

Review 5.  Do nitrates differ?

Authors:  H L Fung
Journal:  Br J Clin Pharmacol       Date:  1992       Impact factor: 4.335

6.  Pharmacokinetics of isosorbide dinitrate and its mononitrate metabolites after intravenous infusion.

Authors:  Y Santoni; A Iliadis; J P Cano; R Luccioni; Y Frances
Journal:  J Pharmacokinet Biopharm       Date:  1986-02

7.  Pharmacokinetics of stereomeric 1,4:3,6-dianhydrohexitol mononitrates in rats.

Authors:  T B Tzeng; H L Fung
Journal:  Pharm Res       Date:  1993-01       Impact factor: 4.200

8.  Fate of isosorbide dinitrate and mononitrates in patients with renal failure.

Authors:  M G Bogaert; M T Rosseel; J Boelaert; R Daneels
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

9.  Pharmacodynamic modeling of the in vitro vasodilating effects of organic mononitrates.

Authors:  T B Tzeng; H L Fung
Journal:  J Pharmacokinet Biopharm       Date:  1992-06

10.  Plasma concentrations of isosorbide dinitrate and its metabolites after chronic high oral dosage in man.

Authors:  S J Shane; J J Iazzetta; A W Chisholm; J F Berka; D Leung
Journal:  Br J Clin Pharmacol       Date:  1978-07       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.